| Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study RM Clifford, WA Davis, KT Batty, TME Davis Diabetes care 28 (4), 771-776, 2005 | 267 | 2005 |
| Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases KF Ilett, BT Ethell, JL Maggs, TME Davis, KT Batty, B Burchell, TQ Binh, ... Drug metabolism and disposition 30 (9), 1005-1012, 2002 | 172 | 2002 |
| A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria KT Batty, LT Anh Thu, TME Davis, KF Ilett, T Xuan Mai, N Canh Hung, ... British journal of clinical pharmacology 45 (2), 123-129, 1998 | 159 | 1998 |
| Selective high-performance liquid chromatographic determination of artesunate and α-and β-dihydroartemisinin in patients with falciparum malaria KT Batty, TME Davis, TQ Binh, TK Anh, KF Ilett Journal of chromatography b: biomedical sciences and applications 677 (2 …, 1996 | 154 | 1996 |
| Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria TME Davis, HL Phuong, KF Ilett, NC Hung, KT Batty, VDB Phuong, ... Antimicrobial agents and chemotherapy 45 (1), 181-186, 2001 | 120 | 2001 |
| Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria TQ Binh, KF Ilett, KT Batty, TME Davis, NC Hung, SM Powell, LTA Thu, ... British journal of clinical pharmacology 51 (6), 541-546, 2001 | 105 | 2001 |
| Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria HA Karunajeewa, KF Ilett, I Mueller, P Siba, I Law, M Page-Sharp, E Lin, ... Antimicrobial agents and chemotherapy 52 (1), 237-243, 2008 | 97 | 2008 |
| The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects. KT Batty, TM Davis, KF Ilett, LJ Dusci, SR Langton British journal of clinical pharmacology 39 (3), 305-311, 1995 | 96 | 1995 |
| Chemical stability of artesunate injection and proposal for its administration by intravenous infusion KT Batty, KF Ilett, ME Davis, Timothy Journal of pharmacy and pharmacology 48 (1), 22-26, 1996 | 84 | 1996 |
| Synthesis and antimalarial evaluation of novel isocryptolepine derivatives LR Whittell, KT Batty, RPM Wong, EM Bolitho, SA Fox, TME Davis, ... Bioorganic & medicinal chemistry 19 (24), 7519-7525, 2011 | 83 | 2011 |
| Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double‐blind, placebo‐controlled trial TME DAVIS, LG DEMBO, SA KAYE‐EDDIE, BJ HEWITT, RG HISLOP, ... British journal of clinical pharmacology 42 (4), 415-421, 1996 | 83 | 1996 |
| Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model BR Moore, M Page-Sharp, JR Stoney, KF Ilett, JD Jago, KT Batty Antimicrobial agents and chemotherapy 55 (8), 3899-3907, 2011 | 82 | 2011 |
| A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria. KT Batty, AT Le, KF Ilett, PT Nguyen, SM Powell, CH Nguyen, XM Truong, ... The American journal of tropical medicine and hygiene 59 (5), 823-827, 1998 | 75 | 1998 |
| A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic RM Clifford, KT Batty, TME Davis, W Davis, G Stein, G Stewart, ... International Journal of Pharmacy Practice 10 (2), 85-89, 2002 | 70 | 2002 |
| The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria KF Ilett, KT Batty, SM Powell, TQ Binh, LTA Thu, HL Phuong, NC Hung, ... British journal of clinical pharmacology 53 (1), 23-30, 2002 | 70 | 2002 |
| Penetration of dihydroartemisinin into cerebrospinal fluid after administration of intravenous artesunate in severe falciparum malaria TME Davis, TQ Binh, KF Ilett, KT Batty, HL Phuöng, GM Chiswell, ... Antimicrobial agents and chemotherapy 47 (1), 368-370, 2003 | 67 | 2003 |
| Role of P glycoprotein in absorption of novel antimalarial drugs A Crowe, KF Ilett, HA Karunajeewa, KT Batty, TME Davis Antimicrobial agents and chemotherapy 50 (10), 3504-3506, 2006 | 53 | 2006 |
| Protein binding and α : β anomer ratio of dihydroartemisinin in vivo KT Batty, KF Ilett, TME Davis British journal of clinical pharmacology 57 (4), 529-533, 2004 | 53 | 2004 |
| Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study KT Batty, S Salman, BR Moore, J Benjamin, ST Lee, M Page-Sharp, ... Antimicrobial agents and chemotherapy 56 (5), 2472-2484, 2012 | 46 | 2012 |
| Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean … JM Benjamin, BR Moore, S Salman, M Page-Sharp, S Tawat, G Yadi, ... Antimicrobial agents and chemotherapy 59 (7), 4260-4271, 2015 | 42 | 2015 |
Timothy M E DavisProfessor of MedicineVerified email at uwa.edu.au
